# Mirum Pharmaceuticals, Inc. (MIRM): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/mirm for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $80.39 USD |
| Market Cap | $5.22B |
| P/E (TTM) | — |
| EPS (TTM) | −$14.55 |
| 52-Week Range | $63.23 – $130.00 |
| Dividend Yield (TTM) | — |

## Dividend

MIRM has no dividend payment history in our records.

## Frequently Asked Questions

### What does Mirum Pharmaceuticals, Inc. do?

Mirum Pharmaceuticals, Inc. (MIRM) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is MIRM's market cap?

Mirum Pharmaceuticals, Inc. (MIRM) has a market capitalization of approximately $5.22 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does MIRM pay a dividend?

No, Mirum Pharmaceuticals, Inc. (MIRM) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is MIRM profitable?

Mirum Pharmaceuticals, Inc. (MIRM) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has MIRM ever paid a dividend?

No. Dividend Data's records show no dividend payments from Mirum Pharmaceuticals, Inc. (MIRM). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/mirm
- Dividend history & safety: https://www.dividenddata.com/stocks/mirm/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/mirm/earnings
- Financial statements: https://www.dividenddata.com/stocks/mirm/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/mirm/valuation
- Peer comparison: https://www.dividenddata.com/stocks/mirm/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.